Literature DB >> 10992680

Hepatocellular carcinoma: an emerging problem with hepatitis C.

L Jeffers1.   

Abstract

Hepatocellular carcinoma (HCC) is emerging as a major problem in the United States, primarily due to the development of liver cancer in patients with cirrhosis secondary to the hepatitis C virus. The diagnosis of HCC in patients with underlying cirrhosis can be achieved at an early stage if appropriate diagnostic measures are pursued by primary care physicians and gastroenterologists. African Americans are particularly vulnerable in developing HCC since their response to current therapy for chronic hepatitis C is less than optimal.

Entities:  

Mesh:

Year:  2000        PMID: 10992680      PMCID: PMC2608613     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  2 in total

1.  Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.

Authors:  G Fattovich; G Giustina; F Degos; F Tremolada; G Diodati; P Almasio; F Nevens; A Solinas; D Mura; J T Brouwer; H Thomas; C Njapoum; C Casarin; P Bonetti; P Fuschi; J Basho; A Tocco; A Bhalla; R Galassini; F Noventa; S W Schalm; G Realdi
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

2.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Authors:  V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 176.079

  2 in total
  8 in total

1.  Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance.

Authors:  Sandip K Bose; Shubham Shrivastava; Keith Meyer; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

2.  Generation of infectious hepatitis C virus in immortalized human hepatocytes.

Authors:  Tatsuo Kanda; Arnab Basu; Robert Steele; Takaji Wakita; Jan S Ryerse; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signaling pathway for insulin resistance.

Authors:  Sutapa Banerjee; Kousuke Saito; Malika Ait-Goughoulte; Keith Meyer; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

4.  Hepatitis C virus genotype 1a growth and induction of autophagy.

Authors:  Malika Ait-Goughoulte; Tatsuo Kanda; Keith Meyer; Jan S Ryerse; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

5.  Inhibition of HCV 5'-NTR and core expression by a small hairpin RNA delivered by a histone gene carrier, HPhA.

Authors:  Yanhua Ding; Hong Zhang; Yuxiang Li; Di Wu; Shumei He; Yang Wang; Yuanyuan Li; Feng Wang; Junqi Niu
Journal:  Int J Med Sci       Date:  2013-06-09       Impact factor: 3.738

6.  Association of hepatitis C virus with insulin resistance: evidences from animal studies and clinical studies.

Authors:  Sadaf Badar; Bushra Khubaib; Muhammad Idrees; Abrar Hussain; Zunaira Awan; Sadia Butt; Samia Afzal; Madeeha Akram; Zareen Fatima; Mahwish Aftab; Sana Saleem; Sara Munir; Bisma Rauff; Mahrukh Naudhani; Liaquat Ali; Muhammaad Ali; Irshadul Rehman
Journal:  Hepat Mon       Date:  2012-01-20       Impact factor: 0.660

7.  The expression of HtrA2 and its diagnostic value in patients with hepatocellular carcinoma.

Authors:  Honggang Wang; Fuguo Jiang; Furong Hao; Ruixue Ju
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

8.  Target delivery of small interfering RNAs with vitamin E-coupled nanoparticles for treating hepatitis C.

Authors:  Liang Duan; Yan Yan; Jingyi Liu; Bo Wang; Pu Li; Qin Hu; Weixian Chen
Journal:  Sci Rep       Date:  2016-04-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.